12 chapters, 500+ pages, 267 exhibits, nearly 1,200 endnotes: There is nothing else available that comes close to this valuable resource.
We are providing you with the opportunity to preorder this thoroughly updated, revised, and expanded 2025 edition at special discounted prices. This means that you can be among the first to access our new report. Those who preorder will receive a download link before March 18.
- Download a free 30-page pre-publication overview (including key industry trends, What's New in this edition, the Table of Contents, and a List of Exhibits)
Email Paula Fein (paula@drugchannels.net) if you’d like to bundle the report purchase with access to DCI’s video webinars.
Special preorder and launch pricing discounts will be valid through March 31, 2025.
Read on for more details.
The 2025 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers contains the most current market and industry data available, including DCI’s annual analyses of the market positions of the largest pharmacies, specialty pharmacies, and PBMs. Throughout the report, we have added new industry data, deepened our coverage of many topics, and added more trending information.
This definitive, nonpartisan report will aid pharmaceutical manufacturers, wholesalers, pharmacists, pharmacy owners, hospital executives, pharmacy buyers, benefit managers, managed care executives, policy analysts, investors, consultants, and anyone else who wants to understand and benefit from this ever-changing industry.
This 2025 edition includes substantial new material—outlined on page ix of the report overview. We have also made some significant structural changes to reflect the industry’s evolution. Download the 30-page report overview for more details on the new sections and content.
The chart below illustrates the depth and breadth of the 2025 edition. The numbers indicate the report chapter that corresponds to, explains, and analyzes each channel flow.
Thank you for your interest in our work. If you have any questions before purchasing a license to the report, please email me. Enjoy!
No comments:
Post a Comment